<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-SPF098H7</udiDi>
    <basicUdiDi>B-SPF098H7</basicUdiDi>
    <tradeName>D-SPF098H7</tradeName>
    <deviceName>STYLAGE® Hydro</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF098</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:59:23.774Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-3662824ZT</udiDi>
    <basicUdiDi>B-3662824ZT</basicUdiDi>
    <tradeName>E-One Clinic RC</tradeName>
    <deviceName>E-One Clinic RC</deviceName>
    <manufacturerName>E-SWIN SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000011807</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0502</emdnCode>
    <emdnDescription>HIGH INTENSITY ELECTROMAGNETIC RADIATION EMITTING EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED FOR USE ON THE HUMAN BODY, FOR SKIN RESURFACING, TATTOO OR HAIR REMOVAL OR OTHER SKIN TREATMENT – INTENSE PULSED LIGHT</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>D002AF004Bxxx</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:38:13.918Z</lastUpdated>
  </row>
  <row>
    <udiDi>33760247360012</udiDi>
    <basicUdiDi>B-33760247360012</basicUdiDi>
    <tradeName>Spring Thread</tradeName>
    <deviceName>Spring Thread FA 6-300</deviceName>
    <manufacturerName>1st SurgiConcept</manufacturerName>
    <manufacturerSrn>FR-MF-000010988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FA 6-300 x6</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:19:49.656Z</lastUpdated>
  </row>
  <row>
    <udiDi>33760247360005</udiDi>
    <basicUdiDi>B-33760247360005</basicUdiDi>
    <tradeName>Spring Thread</tradeName>
    <deviceName>Spring Thread FL 6-300</deviceName>
    <manufacturerName>1st SurgiConcept</manufacturerName>
    <manufacturerSrn>FR-MF-000010988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X020102</emdnCode>
    <emdnDescription>PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE TOTALLY INTRODUCED INTO THE HUMAN BODY THROUGH SURGICALLY INVASIVE MEANS FOR THE PURPOSE OF MODIFYING THE ANATOMY OF BODY PARTS WITH THE EXCEPTION OF TATTOOING PRODUCTS AND PIERCINGS – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FL 6-300 x6</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T15:19:48.856Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-084420P5</udiDi>
    <basicUdiDi>B-084420P5</basicUdiDi>
    <tradeName>Sculptra</tradeName>
    <deviceName>Sculptra</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>084420</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:13:19.503Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-084419PL</udiDi>
    <basicUdiDi>B-084419PL</basicUdiDi>
    <tradeName>Sculptra</tradeName>
    <deviceName>Sculptra</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>084419</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:13:17.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-084418PJ</udiDi>
    <basicUdiDi>B-084418PJ</basicUdiDi>
    <tradeName>Sculptra</tradeName>
    <deviceName>Sculptra</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>084418</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:13:15.860Z</lastUpdated>
  </row>
  <row>
    <udiDi>06972978060109</udiDi>
    <basicUdiDi>B-06972978060109</basicUdiDi>
    <tradeName>RENUVA</tradeName>
    <deviceName>Medical Non-ablative Fractional Laser Systems</deviceName>
    <manufacturerName>Wingderm Electro-Optics Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000007136</manufacturerSrn>
    <authorisedRepresentativeName>Prolinx GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005129</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0501</emdnCode>
    <emdnDescription>HIGH INTENSITY ELECTROMAGNETIC RADIATION EMITTING EQUIPMENT WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED FOR USE ON THE HUMAN BODY, FOR SKIN RESURFACING, TATTOO OR HAIR REMOVAL OR OTHER SKIN TREATMENT – LASER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WFA-01</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T13:18:09.505Z</lastUpdated>
  </row>
  <row>
    <udiDi>05060033043660</udiDi>
    <basicUdiDi>B-05060033043660</basicUdiDi>
    <tradeName>Perfectha Lidocaine</tradeName>
    <deviceName>Perfectha Subskin Lidocaine</deviceName>
    <manufacturerName>Sinclair France SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000008945</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PDSSL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-06T05:23:04.457Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535540</udiDi>
    <basicUdiDi>B-03760208535540</basicUdiDi>
    <tradeName>03760208535540</tradeName>
    <deviceName>STYLAGE® Special Lips Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF567</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:46.747Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535557</udiDi>
    <basicUdiDi>B-03760208535557</basicUdiDi>
    <tradeName>03760208535557</tradeName>
    <deviceName>STYLAGE® Special Lips Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF568</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:45.143Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535526</udiDi>
    <basicUdiDi>B-03760208535526</basicUdiDi>
    <tradeName>03760208535526</tradeName>
    <deviceName>STYLAGE® XXL Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF565</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:44.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535533</udiDi>
    <basicUdiDi>B-03760208535533</basicUdiDi>
    <tradeName>03760208535533</tradeName>
    <deviceName>STYLAGE® XXL Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF566</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:41.951Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535519</udiDi>
    <basicUdiDi>B-03760208535519</basicUdiDi>
    <tradeName>03760208535519</tradeName>
    <deviceName>STYLAGE® MEPIVACAINE</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF564</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:26.681Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535502</udiDi>
    <basicUdiDi>B-03760208535502</basicUdiDi>
    <tradeName>03760208535502</tradeName>
    <deviceName>STYLAGE® XL Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF563</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:25.091Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535496</udiDi>
    <basicUdiDi>B-03760208535496</basicUdiDi>
    <tradeName>03760208535496</tradeName>
    <deviceName>STYLAGE® L Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF562</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:24.287Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535489</udiDi>
    <basicUdiDi>B-03760208535489</basicUdiDi>
    <tradeName>03760208535489</tradeName>
    <deviceName>STYLAGE® L Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF561</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:22.682Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535472</udiDi>
    <basicUdiDi>B-03760208535472</basicUdiDi>
    <tradeName>03760208535472</tradeName>
    <deviceName>STYLAGE® M Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF560</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:19.482Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535465</udiDi>
    <basicUdiDi>B-03760208535465</basicUdiDi>
    <tradeName>03760208535465</tradeName>
    <deviceName>STYLAGE® M Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF559</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:17.874Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760208535458</udiDi>
    <basicUdiDi>B-03760208535458</basicUdiDi>
    <tradeName>03760208535458</tradeName>
    <deviceName>STYLAGE® S Mepivacaine</deviceName>
    <manufacturerName>LABORATOIRES VIVACY</manufacturerName>
    <manufacturerSrn>FR-MF-000003771</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPF558</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T18:38:17.069Z</lastUpdated>
  </row>
</eudamedExport>